Increase/Decrease in Cash (Quarterly)

Increase/Decrease in Cash: The total change in cash for the company over the given period.

Nutex Health Inc. (NUTX) had Increase/Decrease in Cash of $144.93M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$151.68M
Net Income	$11.83M
Cost of Goods Sold	$105.54M
Gross Profit	$46.14M
Operating Expenses	$120.76M
Operating Income	$30.92M
Non-Operating Income/Expense	$-5.02M
Pre-Tax Income	$25.89M
Normalized Pre-Tax Income	$25.89M
Income after Taxes	$16.61M
Income from Continuous Operations	$16.61M
Consolidated Net Income/Loss	$16.61M
Normalized Income after Taxes	$16.61M
EBIT	$30.92M
EBITDA	$36.11M
Weighted-Average Shares Outstanding (Basic)	6.36M
Weighted-Average Shares Outstanding (Diluted)	6.76M
Earnings per Share (EPS) (Basic)	$2.07
Earnings per Share (EPS) (Diluted)	$2.34
Balance Sheet Financials
Current Assets	$538.81M
Property, Plant, and Equipment	$94.58M
Long-Term Assets	$379.71M
Total Assets	$918.52M
Current Liabilities	$157.91M
Long-Term Debt	$298.05M
Long-Term Liabilities	$337.18M
Total Liabilities	$495.09M
Common Equity	$423.44M
Tangible Shareholders Equity	$388.29M
Shareholders Equity	$423.44M
Common Shares Outstanding	7.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$248.12M
Cash Flow from Investing Activities	$-5.24M
Cash Flow from Financial Activities	$-97.95M
Beginning Cash	$40.64M
End Cash	$185.57M
Increase/Decrease in Cash	$144.93M
Stock-Based Compensation	$117.00M
Common Stock Dividends Paid	$-74.28M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.41
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.75
Gross Margin	30.42%
Operating Margin	20.38%
EBIT Margin	20.38%
EBITDA Margin	--
Pre-Tax Profit Margin	17.07%
Profit Margin	7.80%
Free Cash Flow	$245.60M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	36.83
Receiveable Turnover	0.47
Days Sales in Receivables	193.09
Return on Equity	3.92%
Return on Tangible Equity	4.28%
Return on Assets	1.81%
Return on Investments	2.30%
Book Value Per Share	$59.75
Free Cash Flow per Share	$36.35
Operating Cash Flow per Share	$36.73

Data from Zacks Investment Research, Inc.